{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1624941", "DateCompleted": {"Year": "1992", "Month": "08", "Day": "07"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "55", "Issue": "2", "PubDate": {"Year": "1992", "Month": "Feb"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Anti-HIV and cytotoxic alkaloids from Buchenavia capitata.", "Pagination": {"StartPage": "207", "EndPage": "213", "MedlinePgn": "207-13"}, "Abstract": {"AbstractText": ["The anti-HIV activity in the organic solvent extract of leaves of Buchenavia capitata was traced to a series of known flavonoid alkaloids, which represent a new chemotype for anti-HIV activity. The 13C-nmr assignments for this series of compounds have been revised. O-Demethylbuchenavianine [1] was the most active compound of the series but produced only moderate cytoprotective effects against HIV in cultured human lymphoblastoid (CEM-SS) cells. Compound 1 was cytotoxic also in the NCI human disease-oriented in vitro tumor screening panel and produced a pattern of modest differential cellular sensitivity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Discovery Research and Development, National Cancer Institute, Frederick, Maryland 21702-1201."}], "LastName": "Beutler", "ForeName": "J A", "Initials": "JA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cardellina", "ForeName": "J H", "Initials": "JH", "Suffix": "2nd"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "McMahon", "ForeName": "J B", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Boyd", "ForeName": "M R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cragg", "ForeName": "G M", "Initials": "GM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA, Neoplasm"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA, Viral"}, {"RegistryNumber": "0", "NameOfSubstance": "HIV Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA, Neoplasm"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA, Viral"}, {"QualifierName": [], "DescriptorName": "HIV Protease Inhibitors"}, {"QualifierName": ["drug effects"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "2", "Day": "1"}, {"Year": "1992", "Month": "2", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "2", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1624941", "10.1021/np50080a008"]}}]}